Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Aurinia Pharmaceuticals Inc (AUPH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aurinia Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.910 +0.040    +0.82%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
4.900
-0.010
-0.202%
0:43:37 - Real-time Data
  • Volume: 969,046
  • Bid/Ask: 4.900 / 4.950
  • Day's Range: 4.860 - 5.000
Type:  Equity
Market:  United States
Aurinia Pharma 4.910 +0.040 +0.82%

Aurinia Pharma Company Profile

 
Read the Aurinia Pharmaceuticals Inc company profile to learn more about the business and the management team. View Aurinia Pharmaceuticals Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

300

Equity Type

ORD

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Contact Information

Address 118 Avenue , 14315 Suite 140
Edmonton, T5L 4S6
Canada
Phone 250 744 2487
Fax 250 708 4345

Top Executives

Name Age Since Title
Peter S. Greenleaf 54 2019 President, CEO & Director
Brinda Balakrishnan 43 2021 Independent Director
Robert T. Foster 66 1993 Director
Karen L. Smith 56 2023 Director
David R. W. Jayne 67 2015 Independent Non-Executive Director
Daniel G. Billen 70 2019 Chairman
Jill Diane Leversage 68 2019 Independent Director
Jeffrey Allen Bailey 62 2023 Director
R. Hector Mackay-Dunn 73 2019 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AUPH Price Commentary

Write your thoughts about Aurinia Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Koo Wei
Koo Wei Dec 13, 2021 19:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$Myovant Sciences Ltd.(MYOV)$ ‌Target of acquisition by Sumi who is facing patent cliff and already bought out 4 others “vant”companies. Besides, the fundamentals are strong here… 2 blockbuster drugs approved and commercialised by ‌$Pfizer(PFE)$ ‌with tiered payment for 4.2billion.. MYOV also holding cash in excess of 600millions with a market capital of $1.3billion. Definitelya good buyout at $30 minimum. Let’s take this opportunity to stand up against the giants who has been manupulating this and robbing the common investors like us
Jules Femi Onalaja
Jules Femi Onalaja Apr 21, 2021 18:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get out before earning report. Peter Greenleaf & Mgt don't have a clue what they are doing. 52wk low.
Ken Laing
Ken Laing Apr 16, 2021 9:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get in before the earnings report
Ken Laing
Ken Laing Mar 05, 2021 16:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to buy
David Millen
David Millen Mar 05, 2021 16:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good call.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email